Polymer-free Sirolimus-eluting Coronary Stent System
- UID
- IMP/MD/2020/000472_55758c2c5fb023ac26a00028f17670bd_5c10bd524e28ecde5f1f121d79443804
- Device class
- Class D
- Brand name
- Ultraskin
- License holder
- M/s LepuCare (India) Vascular Solutions Pvt. Ltd.,
- Approving authority
- CDSCO
- Product information
- The Nano+ stent system is indicated for use in: • Patients with localized stenosis lesions whose reference vessel diameters are larger than 2.25 mm and need stenting to prevent restenosis. • Patients with vascular dissection and (Ultraskin) tear. • Patients with restenosis after simple balloon dilatation. • Patients with acute vascular occlusion and close to vascular occlusion within coronary intervention surgery.
Polymer-free Sirolimus-eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000472_55758c2c5fb023ac26a00028f17670bd_5c10bd524e28ecde5f1f121d79443804. This device is marketed under the brand name Ultraskin. The license holder is M/s LepuCare (India) Vascular Solutions Pvt. Ltd.,, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.